25 Feb, 2021 08:24 AM
IVE Group Limited (IVE Group or The Company, ASX:IGL) is pleased to announce its results for the six months ended 31 December 2020 (1H FY21).
The strength of IVE's client relationships, flexi...read more
27 Jan, 2021 08:59 AM
Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutep” or “the Company”), a biotechnology company developing novel immunotherapy treatments for cancer and autoimmune disease, ann...read more
22 Jan, 2021 08:57 AM
Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutep” or “the Company”), a biotechnology company developing novel immunotherapy treatments for cancer and autoimmune disease, pro...read more
22 Jan, 2021 08:54 AM
Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutep” or “the Company”), a biotechnology company developing novel immunotherapy treatments for cancer and autoimmune disease, adv...read more
07 Jan, 2021 09:33 AM
Immutep Limited (ASX: IMM; NASDAQ: IMMP) a biotechnology company developing novel immunotherapy treatments for cancer and autoimmune diseases, is pleased to report it has enrolled and safely dosed t...read more
30 Dec, 2020 08:20 AM
Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutep“ or “the Company“), a biotechnology company developing novel immunotherapy treatments for cancer and autoimmune disease, is ...read more